시장보고서

상품코드

1493325

미국의 체외수정 시장 규모, 점유율, 동향 분석 리포트 : 기기별, 시술 유형별, 최종 용도별, 부문별 예측(2024-2030년)

U.S. In Vitro Fertilization Market Size, Share & Trends Analysis Report By Instrument (Disposable Devices, Capital Equipment) By Procedure Type (Fresh Donor, Frozen Donor) By End-use, And Segment Forecasts, 2024 - 2030

발행일: 2024년 05월 | 리서치사:

Grand View Research | 페이지 정보: 영문 70 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

미국의 체외수정 시장 성장과 동향 :

Grand View Research, Inc.의 최신 리포트에 따르면 미국의 체외수정 시장 규모는 2024-2030년 CAGR 4.4%로 확대하며, 2030년에는 72억 4,000만 달러에 달할 것으로 예측되고 있습니다.

부부 불임의 유병률 증가, 체외수정 기술 및 방법의 지속적인 발전, 가족에 대한 사회적 규범과 태도의 변화는 미국내 체외수정 서비스에 대한 수요 증가에 크게 기여하고 있습니다.

체외수정을 포함한 보조생식술을 둘러싼 규제 환경도 시장 역학에 영향을 미치고 있습니다. 체외수정 시술, 클리닉 인증 기준, 윤리적 고려사항을 규정하는 규제는 미국내 체외수정 서비스의 접근성과 품질에 영향을 미칩니다. 규제 변화는 치료 비용, 클리닉 운영, 환자 안전과 같은 요인에 영향을 미쳐 시장 성장을 가속하거나 저해할 수 있습니다.

불임 문제와 치료법에 대한 대중의 인식이 높아지면서 미국 체외수정 시장의 성장을 가속하는 데 중요한 역할을 하고 있습니다. 교육 캠페인, 언론 보도 및 옹호 활동은 불임에 대한 비인간적인 인식을 개선하고 체외수정과 같은 불임 치료법에 대한 이해를 높이는 데 도움이 되고 있습니다. 인식이 높아짐에 따라 사람들은 체외수정을 통한 불임치료에 대한 충분한 정보를 바탕으로 결정을 내릴 수 있게 되었습니다.

미국 체외수정 시장 보고서 하이라이트

기기별로는 배양배지 분야가 2023년 약 40%의 점유율을 차지하며 시장을 독점하고 있습니다.
일회용 기기 분야는 예측 기간 중 가장 빠른 CAGR로 성장할 것으로 예상됩니다.
시술 유형별로 보면 신선 비공여 분야가 2023년 45% 이상의 가장 큰 시장 점유율을 차지했습니다. 신선주기는 성공적인 임신을 위해 더 적은 치료 주기가 필요하기 때문에 비용 효율성이 높은 것으로 인식되는 경우가 많습니다.
냉동 기증자는 편리함과 유연성으로 인해 예측 기간 중 가장 빠른 CAGR을 나타낼 것으로 예상됩니다.
불임 클리닉 시장은 2023년 약 80%의 점유율을 차지하며 예측 기간 중 가장 빠른 CAGR로 성장할 것으로 예상됩니다.
ART 치료에 대한 수요가 증가함에 따라 불임 치료 클리닉과 ART 센터의 수가 크게 증가했습니다.
2023년 10월, Merck &Co.는 직원들에게 불임 치료를 위한 금융 서비스를 제공하는 것을 목표로 하는 Fertility benefit program을 시작한다고 발표했습니다. 서비스 범위는 체외수정 치료, 불임 검사, 호르몬 치료 등입니다.

주요 시장 참여 기업에 의한 최근 동향과 영향 분석
기업/경쟁 분류
벤더 구도
기업 개요
- Bayer AG
- Cook Medical LLC
- EMD Serono, Inc.
- Ferring BV
- FUJIFILM Irvine Scientific(FUJIFILM Holdings Corporation)
- Genea Biomedx
- EMD Serono, Inc.(Merck KGaA)
- Merck &Co., Inc.
- The Cooper Companies, Inc.
- Thermo Fisher Scientific, Inc.
- Vitrolife
- Nova IVF
- RMA Network(Reproductive Medicine Associates)
- US Fertility

KSA 24.06.20

U.S. In Vitro Fertilization Market Growth & Trends:

The U.S. in vitro fertilization market size is anticipated to reach USD 7.24 billion by 2030, expanding at a CAGR of 4.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of infertility among couples, the continuous advancements in IVF technology and techniques, and the shift in societal norms and attitudes toward family have significantly contributed to the increasing demand for IVF services in the U.S.

The regulatory landscape surrounding assisted reproductive technologies, including IVF, also influences market dynamics. Regulations governing IVF practices, clinic accreditation standards, and ethical considerations impact the accessibility and quality of IVF services in the U.S. Changes in regulations can either facilitate or hinder market growth by affecting factors such as treatment costs, clinic operations, and patient safety.

Increased public awareness about infertility issues and available treatment options has played a crucial role in driving the growth of the U.S. IVF market. Educational campaigns, media coverage, and advocacy efforts have helped destigmatize infertility and promote understanding about fertility treatments like IVF. Greater awareness empowers individuals to make informed decisions about seeking fertility assistance through IVF.

U.S. In Vitro Fertilization Market Report Highlights:

Based on instruments, the culture media segment dominated the market with around 40% share in 2023 owing to as availability of funding and an increase in research activities
The disposable devices segment is expected to grow at the fastest CAGR over the forecast period
Based on procedure type, the fresh non-donor segment held the largest market share of over 45% in 2023. Fresh cycles are often perceived as more cost-effective due to potentially requiring fewer treatment cycles to achieve a successful pregnancy
Frozen donors are expected to register the fastest CAGR during the forecast period owing to the convenience and flexibility offered by them
The fertility clinics segment dominated the market with around 80% share in 2023 and is expected to grow at the fastest CAGR over the forecast period
The increasing demand for ART treatments has led to a significant rise in the number of fertility clinics and ART centers
In October 2023, Merck & Co. announced the launch of Fertility benefit program with the aim to provide financial services to employees for fertility treatments. The range of services includes IVF treatments, fertility tests, and hormonal treatments

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Instrument
- 1.2.2. Procedure type
- 1.2.3. End-use
- 1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Instrument outlook
- 2.2.2. Procedure type
- 2.2.3. End-use
2.3. Competitive Insights

Chapter 3. U.S. In Vitro Fertilization Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
3.3. U.S. In Vitro Fertilization Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Supplier power
  - 3.3.1.2. Buyer power
  - 3.3.1.3. Substitution threat
  - 3.3.1.4. Threat of new entrant
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Technological landscape
  - 3.3.2.3. Economic landscape

Chapter 4. U.S. In Vitro Fertilization Market: Instrument Estimates & Trend Analysis

4.1. Instrument Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. U.S. In Vitro Fertilization Market by Instrument Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
- 4.4.1. Disposable media
  - 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2. Culture media
  - 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.2.2. Cryopreservation Media
  - 4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.2.3. Embryo culture media
  - 4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.2.4. Ovum Processing Media
  - 4.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.2.5. Sperm Processing Media
  - 4.4.2.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.3. Capital Equipment
  - 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.3.2. Sperm Analyzer Systems
  - 4.4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.3.3. Imaging Systems
  - 4.4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.3.4. Ovum Aspiration Pumps
  - 4.4.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.3.5. Micromanipulator Systems
  - 4.4.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.3.6. Incubators
  - 4.4.3.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.3.7. Gas Analyzers
  - 4.4.3.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.3.8. Laser Systems
  - 4.4.3.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.3.9. Cryosystems
  - 4.4.3.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.3.10. Sperm Separation Devices
  - 4.4.3.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.3.11. IVF Cabinets
  - 4.4.3.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.3.12. Anti-vibration Tables
  - 4.4.3.12.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.3.13. Witness Systems
  - 4.4.3.13.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.3.14. Other
  - 4.4.3.14.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. In Vitro Fertilization Market: Procedure Type Estimates & Trend Analysis

5.1. Procedure Type Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. U.S. In Vitro Fertilization Market by Procedure Type Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
- 5.4.1. Fresh Donor
  - 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.2. Frozen Donor
  - 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.3. Fresh Non-donor
  - 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.4. Frozen Non-donor
  - 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. U.S. In Vitro Fertilization Market: End-use Estimates & Trend Analysis

6.1. End-use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. U.S. In Vitro Fertilization Market by End-use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
- 6.4.1. Fertility Clinics
  - 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.2. Hospitals & Others Setting
  - 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
- 7.3.1. List of key distributors and channel partners
- 7.3.2. Key customers
- 7.3.3. Key company heat map analysis, 2023
7.4. Company Profiles
- 7.4.1. Bayer AG
  - 7.4.1.1. Company overview
  - 7.4.1.2. Financial performance
  - 7.4.1.3. Product benchmarking
  - 7.4.1.4. Strategic initiatives
- 7.4.2. Cook Medical LLC
  - 7.4.2.1. Company overview
  - 7.4.2.2. Financial performance
  - 7.4.2.3. Product benchmarking
  - 7.4.2.4. Strategic initiatives
- 7.4.3. EMD Serono, Inc.
  - 7.4.3.1. Company overview
  - 7.4.3.2. Financial performance
  - 7.4.3.3. Product benchmarking
  - 7.4.3.4. Strategic initiatives
- 7.4.4. Ferring B.V.
  - 7.4.4.1. Company overview
  - 7.4.4.2. Financial performance
  - 7.4.4.3. Product benchmarking
  - 7.4.4.4. Strategic initiatives
- 7.4.5. FUJIFILM Irvine Scientific (FUJIFILM Holdings Corporation)
  - 7.4.5.1. Company overview
  - 7.4.5.2. Financial performance
  - 7.4.5.3. Product benchmarking
  - 7.4.5.4. Strategic initiatives
- 7.4.6. Genea Biomedx
  - 7.4.6.1. Company overview
  - 7.4.6.2. Financial performance
  - 7.4.6.3. Product benchmarking
  - 7.4.6.4. Strategic initiatives
- 7.4.7. EMD Serono, Inc. (Merck KGaA)
  - 7.4.7.1. Company overview
  - 7.4.7.2. Financial performance
  - 7.4.7.3. Product benchmarking
  - 7.4.7.4. Strategic initiatives
- 7.4.8. Merck & Co., Inc.
  - 7.4.8.1. Company overview
  - 7.4.8.2. Financial performance
  - 7.4.8.3. Product benchmarking
  - 7.4.8.4. Strategic initiatives
- 7.4.9. The Cooper Companies, Inc.
  - 7.4.9.1. Company overview
  - 7.4.9.2. Financial performance
  - 7.4.9.3. Product benchmarking
  - 7.4.9.4. Strategic initiatives
- 7.4.10. Thermo Fisher Scientific, Inc.
  - 7.4.10.1. Company overview
  - 7.4.10.2. Financial performance
  - 7.4.10.3. Product benchmarking
  - 7.4.10.4. Strategic initiatives
- 7.4.11. Vitrolife
  - 7.4.11.1. Company overview
  - 7.4.11.2. Financial performance
  - 7.4.11.3. Product benchmarking
  - 7.4.11.4. Strategic initiatives
- 7.4.12. Nova IVF
  - 7.4.12.1. Company overview
  - 7.4.12.2. Financial performance
  - 7.4.12.3. Product benchmarking
  - 7.4.12.4. Strategic initiativesc
- 7.4.13. RMA Network (Reproductive Medicine Associates)
  - 7.4.13.1. Company overview
  - 7.4.13.2. Financial performance
  - 7.4.13.3. Product benchmarking
  - 7.4.13.4. Strategic initiatives
- 7.4.14. U.S. Fertility
  - 7.4.14.1. Company overview
  - 7.4.14.2. Financial performance
  - 7.4.14.3. Product benchmarking
  - 7.4.14.4. Strategic initiatives

미국의 체외수정 시장 규모, 점유율, 동향 분석 리포트 : 기기별, 시술 유형별, 최종 용도별, 부문별 예측(2024-2030년)

U.S. In Vitro Fertilization Market Size, Share & Trends Analysis Report By Instrument (Disposable Devices, Capital Equipment) By Procedure Type (Fresh Donor, Frozen Donor) By End-use, And Segment Forecasts, 2024 - 2030

미국의 체외수정 시장 성장과 동향 :

미국 체외수정 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 미국의 체외수정 시장 변수, 동향, 범위

제4장 미국의 체외수정 시장 : 기기 추정·동향 분석

제5장 미국의 체외수정 시장 : 시술 유형 추정·동향 분석

제6장 미국의 체외수정 시장 : 최종 용도 추정·동향 분석

제7장 경쟁 구도